CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis

Jenny Thomas; Rosi Wang; Richa Batra; Alexander Böhner; Natalie Garzorz-Stark; Bernadette Eberlein; Fabian Theis; Tilo Biedermann; Carsten Schmidt-Weber; Alexander Zink; Kilian Eyerich; Stefanie Eyerich

doi:10.1016/j.jid.2020.05.122

CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis

Jenny Thomas, Rosi Wang, Richa Batra, Alexander Böhner, Natalie Garzorz-Stark, Bernadette Eberlein, Fabian Theis, Tilo Biedermann, Carsten Schmidt-Weber, Alexander Zink, Kilian Eyerich, Stefanie Eyerich

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	681-685.e6
Journal	Journal of Investigative Dermatology
Volume	141
Issue number	3
DOIs	https://doi.org/10.1016/j.jid.2020.05.122
State	Published - Mar 2021

Access to Document

10.1016/j.jid.2020.05.122

Cite this

Thomas, J., Wang, R., Batra, R., Böhner, A., Garzorz-Stark, N., Eberlein, B., Theis, F., Biedermann, T., Schmidt-Weber, C., Zink, A., Eyerich, K., & Eyerich, S. (2021). CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis. Journal of Investigative Dermatology, 141(3), 681-685.e6. https://doi.org/10.1016/j.jid.2020.05.122

@article{9f5b3ec09df147e5a8c26a4fb33be800,

title = "CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis",

author = "Jenny Thomas and Rosi Wang and Richa Batra and Alexander B{\"o}hner and Natalie Garzorz-Stark and Bernadette Eberlein and Fabian Theis and Tilo Biedermann and Carsten Schmidt-Weber and Alexander Zink and Kilian Eyerich and Stefanie Eyerich",

note = "Funding Information: We thank Jana S{\"a}nger for excellent technical support. This study was performed with samples of the Biobank Biederstein of the Technical University of Munich (Munich, Germany). This study was supported by a grant of Miltenyi Biotec (Bergisch Gladbach, Germany). Conceptualization: KE, SE, AZ; Data Curation: JT, RW; Formal Analysis: JT, RW, RB, FT; Funding Acquisition: KE, AZ; Investigation: JT, RW; Methodology: JT, KE, SE, AZ; Project Administration: JT, KE, SE, AZ; Resources: KE, SE, AZ, BE, TB, CSW; Software: RB, FT; Supervision: JT, KE, SE, AZ; Validation: JT, RW, KE, SE, NGS, AB; Visualization: JT, RW, KE, SE, NGS; Writing - Original Draft Preparation: JT, RW, KE, SE; Writing - Review and Editing: KE, SE, AZ, BE, TB, CSW Funding Information: We thank Jana S{\"a}nger for excellent technical support. This study was performed with samples of the Biobank Biederstein of the Technical University of Munich (Munich, Germany). This study was supported by a grant of Miltenyi Biotec (Bergisch Gladbach, Germany). ",

year = "2021",

month = mar,

doi = "10.1016/j.jid.2020.05.122",

language = "English",

volume = "141",

pages = "681--685.e6",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

publisher = "Elsevier B.V.",

number = "3",

}

Thomas, J, Wang, R, Batra, R, Böhner, A, Garzorz-Stark, N, Eberlein, B , Theis, F , Biedermann, T , Schmidt-Weber, C, Zink, A, Eyerich, K & Eyerich, S 2021, 'CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis', Journal of Investigative Dermatology, vol. 141, no. 3, pp. 681-685.e6. https://doi.org/10.1016/j.jid.2020.05.122

TY - JOUR

T1 - CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis

AU - Thomas, Jenny

AU - Wang, Rosi

AU - Batra, Richa

AU - Böhner, Alexander

AU - Garzorz-Stark, Natalie

AU - Eberlein, Bernadette

AU - Theis, Fabian

AU - Biedermann, Tilo

AU - Schmidt-Weber, Carsten

AU - Zink, Alexander

AU - Eyerich, Kilian

AU - Eyerich, Stefanie

N1 - Funding Information: We thank Jana Sänger for excellent technical support. This study was performed with samples of the Biobank Biederstein of the Technical University of Munich (Munich, Germany). This study was supported by a grant of Miltenyi Biotec (Bergisch Gladbach, Germany). Conceptualization: KE, SE, AZ; Data Curation: JT, RW; Formal Analysis: JT, RW, RB, FT; Funding Acquisition: KE, AZ; Investigation: JT, RW; Methodology: JT, KE, SE, AZ; Project Administration: JT, KE, SE, AZ; Resources: KE, SE, AZ, BE, TB, CSW; Software: RB, FT; Supervision: JT, KE, SE, AZ; Validation: JT, RW, KE, SE, NGS, AB; Visualization: JT, RW, KE, SE, NGS; Writing - Original Draft Preparation: JT, RW, KE, SE; Writing - Review and Editing: KE, SE, AZ, BE, TB, CSW Funding Information: We thank Jana Sänger for excellent technical support. This study was performed with samples of the Biobank Biederstein of the Technical University of Munich (Munich, Germany). This study was supported by a grant of Miltenyi Biotec (Bergisch Gladbach, Germany).

PY - 2021/3

Y1 - 2021/3

UR - http://www.scopus.com/inward/record.url?scp=85099660848&partnerID=8YFLogxK

U2 - 10.1016/j.jid.2020.05.122

DO - 10.1016/j.jid.2020.05.122

M3 - Article

C2 - 32949565

AN - SCOPUS:85099660848

SN - 0022-202X

VL - 141

SP - 681-685.e6

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

IS - 3

ER -

CD23 Levels on B Cells Determine Long-Term Therapeutic Response in Patients with Atopic Eczema Treated with Selective IgE Immune Apheresis

Access to Document

Other files and links

Cite this